ABSTRACT
Manufacturing and mining sectors are serious pollution sources and risk factors that threaten air quality and human health. We analyzed pollutants at two study sites (Talcher and Brajrajnagar) in Odisha, an area exposed to industrial emissions, in the pre-COVID-19 year (2019) and consecutive pandemic years, including lockdowns (2020 and 2021). We observed that the annual data for pollutant concentration increased at Talcher: PM2.5 (7-10%), CO (29-35%), NO2 and NOx (8-57% at Talcher and 14-19% at Brajrajnagar);while there was slight to substantial increase in PM10 (up to 11%) and a significant increase in O3 (41-88%) at both sites. At Brajrajnagar, there was a decrease in PM2.5 (up to 15%) and CO (around half of pre-lockdown), and a decrease in SO2 concentration was observed (30-86%) at both sites. Substantial premature mortality was recorded, which can be attributed to PM2.5 (16-26%), PM10 (31-43%), NO2 (15-21%), SO2 (4-7%), and O3 (3-6%). This premature mortality caused an economic loss between 86-36 million USD to society. We found that although lockdown periods mitigated the losses, the balance of rest of the year was worse than in 2019. These findings are benchmarks to manage air quality over Asia's largest coalmine fields and similar landscapes.
ABSTRACT
Introduction In response to the national coronavirus disease 2019 (COVID-19) pandemic, all hospitals and medical institutes gave priority to COVID-19 screening and to the management of patients who required hospitalization for COVID-19 infection. Surgical departments postponed all elective operative procedures and provided only essential surgical care to patients who presented with acute surgical conditions or suspected malignancy. Ample literature has emerged during this pandemic regarding the guidelines for safe surgical care. We report our experience during the lockdown period including the surgical procedures performed, the perioperative care provided, and the specific precautions implemented in response to the COVID-19 crisis. Materials and Methods We extracted patient clinical data from the medical records of all surgical patients admitted to our tertiary care hospital between the March 24th, 2020 and May 31st, 2020. Data collected included: patient demographics, surgical diagnoses, surgical procedures, nonoperative management, and patient outcomes. Results Seventy-seven patients were included in this report: 23 patients were managed medically, 28 patients underwent a radiologic intervention, and 23 patients required an operative procedure. In total eight of the 77 patients died due to ongoing sepsis, multiorgan failure, or advanced malignancy. Conclusion During the COVID-19 lockdown period, our surgical team performed many lifesaving surgical procedures and appropriately selected cancer operations. We implemented and standardized essential perioperative measures to reduce the spread of COVID-19 infection. When the lockdown measures were phased out a large number of patients remained in need of delayed elective and semi-elective operative treatment. Hospitals, medical institutes, and surgical leadership must adjust their priorities, foster stewardship of limited surgical care resources, and rapidly implement effective strategies to assure perioperative safety for both patients and operating room staff during periods of crisis.
ABSTRACT
[This corrects the article DOI: 10.1016/j.heliyon.2021.e08124.].
ABSTRACT
The rapid development of safe and effective vaccines against severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) is a necessary response to coronavirus outbreak. Here, we developed PRAK-03202, the world's first triple antigen virus-like particle vaccine candidate, by cloning and transforming SARS-CoV-2 gene segments into a highly characterized S. cerevisiae-based D-Crypt™ platform, which induced SARS CoV-2 specific neutralizing antibodies in BALB/c mice. Immunization using three different doses of PRAK-03202 induced an antigen-specific (spike, envelope, and membrane proteins) humoral response and neutralizing potential. Peripheral blood mononuclear cells from convalescent patients showed lymphocyte proliferation and elevated interferon levels suggestive of epitope conservation and induction of T helper 1-biased cellular immune response when exposed to PRAK-03202. These data support further clinical development and testing of PRAK-03202 for use in humans.